Diagnosis of histoplasmosis by next-generation sequencing of microbial cell-free DNA in Texas
Antimicrobial Stewardship & Healthcare Epidemiology · 2026 · 6 (1)
DOI: 10.1017/ash.2026.10429 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Stewardship & Healthcare Epidemiology, online erschienen am 01.06.2026. Verfasst von Fernando H Centeno und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Section of Infectious Diseases, Baylor College of Medicine, Houston, USA. Die Arbeit nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
We examine the impact of microbial cell-free DNA (mcfDNA) NGS for the diagnosis of Histoplasma capsulatuim in a quaternary referral center in Texas. Of eight included patients, five had a change in their antifungal coverage after mcfDNA NGS results with faster turnaround times than antigen testing and cultures.
Autor:innen und Institutionen
- Department of Medicine, Section of Infectious Diseases, Baylor College of Medicine, Houston, USA.
- Department of Pathology & Immunology, Baylor College of Medicine, Houston, USA.
ORCID-Profile: Fernando H Centeno, Todd Lasco
Zitieren
APA
Centeno, F. H., Lasco, T., & Al Mohajer, M. (2026). Diagnosis of histoplasmosis by next-generation sequencing of microbial cell-free DNA in Texas. Antimicrobial Stewardship & Healthcare Epidemiology, 6(1). https://doi.org/10.1017/ash.2026.10429
Vancouver
Centeno FH, Lasco T, Al Mohajer M. Diagnosis of histoplasmosis by next-generation sequencing of microbial cell-free DNA in Texas. Antimicrobial Stewardship & Healthcare Epidemiology. 2026;6(1). doi:10.1017/ash.2026.10429
BibTeX
@article{Centeno2026,
author = {Centeno, Fernando H and Lasco, Todd and Al Mohajer, Mayar},
title = {Diagnosis of histoplasmosis by next-generation sequencing of microbial cell-free DNA in Texas},
journal = {Antimicrobial Stewardship & Healthcare Epidemiology},
year = {2026},
volume = {6},
number = {1},
doi = {10.1017/ash.2026.10429}
}
EUVIMED